Abstract: An acute kidney injury predicting system and a method thereof are proposed. A processor reads the data to be tested, the detection data, the machine learning algorithm and the risk probability comparison table from a main memory. The processor trains the detection data according to the machine learning algorithm to generate an acute kidney injury prediction model, and inputs the data to be tested into the acute kidney injury prediction model to generate an acute kidney injury characteristic risk probability and a data sequence table. The data sequence table lists the data to be tested in sequence according to a proportion of each of the data to be tested in the acute kidney injury characteristics. The processor selects one of the medical treatment data from the risk probability comparison table according to the acute kidney injury characteristic risk probability.

Abstract: A method for preparing a cyclopeptide and a cyclopeptide preparing by the method are disclosed. The method includes the following steps: (a) providing compounds represented by formulas (I-1) and (I-4); (b) performing a reaction between the compounds of formulas (I-1) and (I-4) to obtain a compound represented by formula (I-5); (c) performing a reaction between the compound of formula (I-5) and the compound represented by formula (I-6) to obtain a compound represented by formula (I-7); (d) performing a cyclization reaction of the compound of formula (I-7) with a catalyst of formula (II) and deprotection to obtain a compound represented by formula (III), wherein the compounds of formulas (I-1), (I-4) to (I-7), (III) and the catalyst of formula (II) are as defined in the specification.

Abstract: A method for preparing a cyclopeptide and a cyclopeptide preparing by the method are disclosed. The method includes the following steps: (A) providing compounds represented by the following formulas (I-1) and (I-2): wherein, G, Ra, Rb, Rc, Rd, and Re are defined in the specification; (B) performing a reaction between the compounds of formulas (I-1) and (I-2) to obtain a compound represented by the following formula (I-3): and (C) performing a cyclization reaction of the compound of formula (I-3) with a catalyst of formula (II) and deprotection to obtain a compound represented by the following formula (III): wherein, G?, Q, M, L1, L2, m, y, and z are defined in the specification.

Abstract: A method for oxidative cleavage of a compound with an unsaturated double bond is provided.

Abstract: A block copolymer is disclosed. The block copolymer has a structure of formula (V) below: [D]x-[E]y-[F]z??(V) wherein D, E, and F are each independently a compound of formula (VI) below, and D, E, and F are different from each other; and x, y, and z are each independently an integer from 1 to 40; wherein A2 is O or S; R7 is H or a C1-6 alkyl; and R8 is a C1-12 alkyl, (CH2)qN(R11)2, CH2(CH2OCH2)rCH2N(R12)2, or CH2(CH2OCH2)sCH2OR13, wherein R11, R12, and R13 are each independently a C1-6 alkyl; and q, r, and s are each independently an integer from 1 to 10.

Abstract: A block copolymer and a method for preparing the same are disclosed. The method comprises the following steps: (A) mixing a compound of formula (I), a catalyst of formula (II), and a first solvent to obtain a first mixture; (B) adding a first monomer into the first mixture for reaction to obtain a second mixture; and (C) adding a second monomer into the second mixture for reaction to obtain a third mixture; wherein the compound of formula (I) and the catalyst of formula (II) are as defined in the specification.

Abstract: A method for preparing a cyclopeptide and a cyclopeptide preparing by the method are disclosed. The method includes the following steps: (A) providing compounds represented by the following formulas (I-1) and (I-2): wherein, G, Ra, Rb, Rc, Rd, and Re are defined in the specification; (B) performing a reaction between the compounds of formulas (I-1) and (I-2) to obtain a compound represented by the following formula (I-3): and (C) performing a cyclization reaction of the compound of formula (I-3) with a catalyst of formula (II) and deprotection to obtain a compound represented by the following formula (III): wherein, G?, Q, M, L1, L2, m, y, and z are defined in the specification.

Abstract: A method for oxidative cleavage of a compound with an unsaturated double bond is provided.

Abstract: An esterification method of a copolymer is disclosed. The esterification method includes the steps of: (A) mixing a copolymer having a carboxylic acid group, an alcohol or an aminoalcohol compound, a catalyst of formula (I), and a first solvent to obtain a first mixture; (B) reacting the first mixture at a predetermined temperature to obtain a second mixture; and (C) adding the second mixture into a second solvent; wherein the catalyst of formula (I) is shown below: [M(O)a]m+Xbn???(I) wherein M, X, a, b, in, and n are defined in the specification.

Abstract: A method for preparing a cyclopeptide, which includes the following steps: (A) providing compounds represented by the following formulas (II-1) or (II?-1) and (II-2); (B) performing a reaction between the compounds of formulas (II-1) or (II?-1) and (II-2), to obtain a compound represented by the following formula (II-3) and (II?-3), respectively; (C) performing a reaction between the compound of formula (II-3) or (II?-3) and a compound represented by the following formula (II-4) or (II?-4), respectively, is performed, to obtain a compound represented by the following formula (II-5), and (II?-5), respectively; (D) performing a cyclization reaction of the compound of formula (II-5) or (II?-5) with a catalyst of formula (III), to obtain a compound represented by the following formula (I) or (I?), respectively. The formulas (I), (I?), (II-1) to (II-5), (II?-1) to (II?-5) and (III) are shown in the specification.

Abstract: A method for preparing a cyclopeptide, which includes the following steps: (A) providing compounds represented by the following formulas (II-1) or (II?-1) and (II-2); (B) performing a reaction between the compounds of formulas (II-1) or (II?-1) and (II-2), to obtain a compound represented by the following formula (II-3) and (II?-3), respectively; (C) performing a reaction between the compound of formula (II-3) or (II?-3) and a compound represented by the following formula (II-4) or (II?-4), respectively, is performed, to obtain a compound represented by the following formula (II-5), and (II?-5), respectively; (D) performing a cyclization reaction of the compound of formula (II-5) or (II?-5) with a catalyst of formula (III), to obtain a compound represented by the following formula (I) or (I?), respectively. The formulas (I), (I?), (II-1) to (II-5), (II?-1) to (II?-5) and (III) are shown in the specification.

Abstract: A cyclopeptide is disclosed, which is represented by the following formula (I) or (I?): wherein R1 is defined in the specification. In addition, a pharmaceutical or cosmetic composition comprising the same and a method for preparing the same are also disclosed.

Abstract: An esterification method of a copolymer is disclosed. The esterification method includes the steps of: (A) mixing a copolymer having a carboxylic acid group, an alcohol or an aminoalcohol compound, a catalyst of formula (I), and a first solvent to obtain a first mixture; (B) reacting the first mixture at a predetermined temperature to obtain a second mixture; and (C) adding the second mixture into a second solvent; wherein the catalyst of formula (I) is shown below: [M(O)a]m+Xbn+??(I) wherein M, X, a, b, in, and n are defined in the specification.

Abstract: A block copolymer and a method for preparing the same are disclosed. The method comprises the following steps: (A) mixing a compound of formula (I), a catalyst of formula (II), and a first solvent to obtain a first mixture; (B) adding a first monomer into the first mixture for reaction to obtain a second mixture; and (C) adding a second monomer into the second mixture for reaction to obtain a third mixture; wherein the compound of formula (I) and the catalyst of formula (II) are as defined in the specification.

Abstract: A novel compound is disclosed, which comprises: a 7-membered ring segment, which is formed by a cis-stilbene segment and a bridge atom with four bonds; and a fluorene segment connecting to the bridge atom with a double bond. In addition, an organic electronic device is also disclosed, and an organic layer therein comprises the novel compound of the present invention.

Abstract: An organic compound is disclosed. The organic compound includes a cis-stilbene segment, a bridge atom segment having a bridge atom with four bonds, and the bridge atom is connected to the cis-stilbene segment with two of the four bonds to form a 7-membered ring structure, and an imidazole segment connected to the cis-stilbene segment.

Abstract: An organic compound is disclosed. The organic compound includes a cis-stilbene segment, a bridge atom segment having a bridge atom with four bonds, and the bridge atom is connected to the cis-stilbene segment with two of the four bonds to form a 7-membered ring structure, and a quinoxaline segment connected to the cis-stilbene segment.

Abstract: The present invention provides a series of spirally configured cis-stilbene/fluorene hybrid compounds and an optoelectronic device comprising the same. The compound comprises a seven-membered ring portion. The seven-membered ring portion is composed of a cis-stilbene fragment, and a tetrahedral coordination bridging atom fragment, wherein the cis-stilbene fragment has at least one substituent, the substituent is independently a substituted or unsubstituted triazine group, pyrimidine group or phenyl group. The compounds have glass transition temperatures ranged from 156° C. to 202° C., decomposition temperatures ranged from 419° C. to 509° C., reversible electron transport property, and balanced charges motilities. In addition, a variety of experimental data have proved that these spirally configured cis-stilbene/fluorene hybrid materials can indeed be used as a hole-blocking type electron-transporter for phosphorescent OLEDs.

Abstract: The present invention provides a series of diphenylimidazole-fused, spirally configured cis-stilbene/fluorene hybrid compounds and an optoelectronic device comprising the same. The diphenylimidazole-fused, spirally configured cis-stilbene/fluorene hybrid compound bearing cyanoaryl and cyanoheteroaryl substituents, and have glass transition temperatures ranged from 154° C. to 194° C., decomposition temperatures ranged from 426° C. to 443° C., reversible electron transport property, and balanced charges motilities. In addition, a variety of experimental data have proved that these diphenylimidazole-fused, spirally configured cis-stilbene/fluorene hybrid materials can indeed be used as a hole-blocking type electron-transporter for phosphorescent OLEDs.

Abstract: A cyclopeptide is disclosed, which is represented by the following formula (I) or (I?): wherein R1 is defined in the specification. In addition, a pharmaceutical or cosmetic composition comprising the same and a method for preparing the same are also disclosed.